Trademark Overview
On Friday, October 4, 2024, a trademark application was filed for AI-BOOST AFFINITY with the United States Patent and Trademark Office. The USPTO has given the AI-BOOST AFFINITY trademark a serial number of 79414786. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 16, 2025. This trademark is owned by ProteoGenix. The AI-BOOST AFFINITY trademark is filed in the Computer & Software Products & Electrical & Scientific Products and Computer & Software Services & Scientific Services categories with the following description:
Computer software used in the context of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; computer software used in the context of antibody discovery and identification; artificial intelligence software used in the context of drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; machine learning software used in the context of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for research, diagnostics, genomics, proteomics, omics and biological products; big data generating software.
Software as a service [SaaS] for a use in the field of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; medicine discovery services; biological research; scientific services and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing; Research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development ...
